Group B Streptococcus (GBS) nucleic acid detection kit (fluorescence PCR method)
Qualitative detection of Group B Streptococcus (GBS) in vaginal and rectal secretions of pregnant women at 35-37 weeks of gestation in vitro.
It is used for antibiotic prophylaxis during childbirth for GBS-positive individuals, thereby reducing maternal and infant infections, improving maternal and infant outcomes, and avoiding antibiotic abuse.
DESCRIPTION
Prevent adverse pregnancy outcomes
Prevent neonatal GBS infection
SPECIFICATION
High sensitivity
The minimum detection limit is 1000 CFU/ml.
Wide coverage of serotypes
Covering the clinically common serotypes of Group B Streptococcus (11 serotypes: Ia, Ib, Ic, II, III, IV, V, VI, VII, VIII, and IX).
Reliable results
Set an internal control to prevent false negatives, and establish a dUTP+UNG enzyme anti-contamination system to avoid false positives.
High precision
The intra-batch and inter-batch precision are both ≤5%.
High specificity
It shows no cross-reactivity with various pathogens that cause similar symptoms.
Fast and efficient
Fully enclosed PCR system, pollution-free, easy to operate, and fast.
Request
